Professional Marketing briefs: February 2013

Share this article:

Telehealth may be a greater part of the future, if docs are assured they will get paid, according to a report by IMS Health's InMedica division. The report noted the CMS policy of penalizing hospitals for readmissions has the potential to be a major driver of increased used of remote monitoring. Researchers also found major opportunity among the post-acute care market, “where healthcare providers are more willing to pay for telehealth if it's part of a total post-acute care model.”

Researchers for communications firm Televox found the digital channel can be better for patients and physicians. The firm said that 34% of the people polled indicated that they were more likely to be honest about medical needs if responding via automated call, email or text message than at a doctor's visit and that patients felt more valued when they received texts, emails and phone calls from HCPs.

The American Academy of Nurse Practitioners and the American College of Nurse Practitioners joined forces December 31 and emerged as the American Association of Nurse Practitioners January 1, 2013. The organization estimates it represents around 155,000 NPs.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?